Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Desvenlafaxine MR (Apo) 50 mg modified release tablet, 28, blister pack |
has TP |
True |
Desvenlafaxine MR (Apo) |
Inferred relationship |
Some |
|
Desvenlafaxine MR (Apo) 50 mg modified release tablet, 14, blister pack |
has TP |
True |
Desvenlafaxine MR (Apo) |
Inferred relationship |
Some |
|
Desvenlafaxine MR (Apo) 50 mg modified release tablet, 7 |
has TP |
True |
Desvenlafaxine MR (Apo) |
Inferred relationship |
Some |
|
Desvenlafaxine MR (Apo) 50 mg modified release tablet, 7, blister pack |
has TP |
True |
Desvenlafaxine MR (Apo) |
Inferred relationship |
Some |
|
Desvenlafaxine MR (Apo) 50 mg modified release tablet, 28 |
has TP |
True |
Desvenlafaxine MR (Apo) |
Inferred relationship |
Some |
|
Desvenlafaxine MR (Apo) 50 mg modified release tablet, 14 |
has TP |
True |
Desvenlafaxine MR (Apo) |
Inferred relationship |
Some |
|
Desvenlafaxine MR (Apo) 50 mg modified release tablet |
Is a |
True |
Desvenlafaxine MR (Apo) |
Inferred relationship |
Some |
|
Desvenlafaxine MR (Apo) 100 mg modified release tablet, 14 |
has TP |
True |
Desvenlafaxine MR (Apo) |
Inferred relationship |
Some |
|
Desvenlafaxine MR (Apo) 100 mg modified release tablet, 7, blister pack |
has TP |
True |
Desvenlafaxine MR (Apo) |
Inferred relationship |
Some |
|
Desvenlafaxine MR (Apo) 100 mg modified release tablet |
Is a |
True |
Desvenlafaxine MR (Apo) |
Inferred relationship |
Some |
|
Desvenlafaxine MR (Apo) 100 mg modified release tablet, 28 |
has TP |
True |
Desvenlafaxine MR (Apo) |
Inferred relationship |
Some |
|
Desvenlafaxine MR (Apo) 100 mg modified release tablet, 14, blister pack |
has TP |
True |
Desvenlafaxine MR (Apo) |
Inferred relationship |
Some |
|
Desvenlafaxine MR (Apo) 100 mg modified release tablet, 7 |
has TP |
True |
Desvenlafaxine MR (Apo) |
Inferred relationship |
Some |
|
Desvenlafaxine MR (Apo) 100 mg modified release tablet, 28, blister pack |
has TP |
True |
Desvenlafaxine MR (Apo) |
Inferred relationship |
Some |
|